Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Importers Notice of Registration - 2016 > Importer of Controlled Substances Registration

Importers Notice of Registration - 2016

[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Page 95647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31273]


Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Registration

ACTION: Notice of registration.

SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

Company FR Docket Published
Rhodes Technologies 81 FR 46956 July 19, 2016
Bellwyck Clinical Services 81 FR 54603 August 16, 2016
Cerilliant Corporation 81 FR 57933 August 24, 2016
Noramco, Inc 81 FR 57932 August 24, 2016
Cody Laboratories, Inc 81 FR 54602 August 16, 2016
AMRI Rensselaer, Inc 81 FR 54603 August 16, 2016
ALMAC Clinical Services Incorp (ACSI) 81 FR 54602 August 16, 2016
Fresenius Kabi USA, LLC 81 FR 54601 August 16, 2016
Akorn, Inc 81 FR 57935 August 24, 2016
Actavis Laboratories FL, Inc 81 FR 54602 August 16, 2016
Unither Manufacturing LLC 81 FR 61250 September 6, 2016
Cambrex Charles City 81 FR 63222 September 14, 2016
United States Pharmacopeial Convention 81 FR 63220 September 14, 2016
R & D Systems, Inc 81 FR 64509 September 20, 2016
Catalent CTS, LLC 81 FR 66081 September 26, 2016

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted registration as importers for schedule I or II controlled substances to the above listed persons.

Dated: December 19, 2016.

Louis J. Milione,
Deputy Assistant Administrator.

[FR Doc. 2016-31273 Filed 12-27-16; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility